$17.49▼-1.04 (-5.61%)
Pre-Market:$17.89+0.41 (+2.32%)
Legend Biotech Corporation (LEGN)
R&D to Revenue
40.31%
Fiscal year · Period ending:

LEGN R&D to Revenue
Latest reported40.31%period ending
Latest reported40.31%period ending
LEGN FY R&D/Revenue (34.73% → 40.31%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
LEGN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 40.3052% | |
| 65.9306% | |
| 134.0443% | |
| 286.8664% | |
| 455.2727% | |
| 309.5467% | |
| 262.0437% | |
| 123.414% | |
| 34.7334% |
Explore More
LEGN Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance